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Accepted 1 October 2009AbstractObjective: To evaluate the pregnancy courses and obstetric outcomes in patients conceived after conservative treatment of endometrial cancer.
Materials and Methods: Case series and systemic review of pregnancy women after fertility-sparing treatment of endometrial cancer. Patients
with early stage endometrial cancer were identified through Tumor Registry in Chang Gung Memorial Hospital between 1990 and 2005 and
MEDLINE search. Diagnosed cases were managed by fertility-sparing therapies. Pregnancies followed by assisted reproductive technology and
spontaneous or ovulation with intrauterine insemination were designated as Group 1 and Group 2, respectively.
Results: Five livebirths in three patients with two sets of twin pregnancy were delivered. Adding 47 women in the MEDLINE search literature,
there were 65 deliveries with 77 livebirths. Groups 1 and 2 had 15 and 50 deliveries, respectively. Group 1 had 23 livebirths including four sets of
twins and two sets of triplets, whereas 54 livebirths consisted of two sets of twins and one set of triplets were noted in Group 2 ( p ¼ 0.003).
Seven preterm deliveries were noted in Group 1 and three in Group 2 ( p ¼ 0.001). Cesarean rate was 93.3% versus 22.0% ( p < 0.001) in Groups
1 and 2, respectively. Pregnancy-induced hypertension and gestational diabetes mellitus were significant between the two groups ( p ¼ 0.035).
One mother died of disease after delivery. No neonatal morbidity was reported.
Conclusions: For women who had completed conservative treatments in early endometrial cancer, assisted reproductive technology provided
a choice of scheduled conception for those with subfertility or chronic anovulation.
Copyright  2011, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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The prevalence of endometrial cancer in women younger
than 40 years of age is 3e5% and tends to be well-differen-
tiated and early stage disease [1]. The standard treatment for
Stage I Grade I carcinoma is total hysterectomy with bilateral
salpingo-oophorectomy [2]. Some of these women who wish
to preserve fertility may not want to undergo definitive
surgical treatment. Kempson and Pokorny [3] reported the first
case of term pregnancy by using progestational agents in well-* Corresponding author. Department of Obstetrics and Gynecology, Chang
Gung Memorial Hospital, Linkou Medical Center, 5 Fu-Shin St., Kueishan,
Taoyuan 333, Taiwan.
E-mail address: hswang@cgmh.org.tw (H.-S. Wang).
1028-4559/$ - see front matter Copyright  2011, Taiwan Association of Obstetri
doi:10.1016/j.tjog.2009.10.006differentiated adenocarcinoma of the endometrium in 1968.
Cases of successful pregnancies under conservative manage-
ment using endometrial curettage and high-dose progestins
to treat endometrial cancer were reported thereafter [3].
However, many of these women suffered from infertility or
subfertility with underlying disorders such as chronic anov-
ulation, obesity, and/or polycystic ovarian syndrome. With the
advance of assisted reproductive technology (ART), pregnan-
cies in these subfertile women have been reported [4e6]. It
has been of limited understanding in assistance with ART to
conception and a paucity of data in obstetric outcomes in these
selected women. In this report, we compared the pregnancy
courses and obstetric outcomes in patients conceived after
conservative treatment of endometrial cancer in tertiary
referral center through a meta-analysis.cs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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The tumor registry at the Chang Gung Memorial Hospital
was searched to identify patients younger than 40 years of age
whowere diagnosed with endometrial cancer between 1990 and
2005. Three patients with conservative management followed
by subsequent conception were included in this study [7,8].
Furthermore, a literature search through MEDLINE database
was conducted to identify young patients using the term
“endometrial cancer”, with subheadings of “pregnancy” and
“conservative treatment” in English language literature from
1968 to 2005.
The bibliographies of these reports were also searched for
additional publications. Use of in vitro fertilization (IVF),
intracytoplasmic sperm injection, gamete intrafallopian trans-
fer, or zygote intrafallopian transfer was designated as Group 1.
Spontaneous pregnancy or ovulation induction with intrauterine
insemination was designated as Group 2. Forty-seven women
had pregnancies either by Group 1 or Group 2. Two cases had
miscarriages with no successful pregnancy were excluded.
Univariate analyses included c2 tests and Fisher’s exact prob-
ability tests. A two-tailed value of p < 0.05 was considered
statistically significant. Statistical analyses were performed
using statistical software SPSS version 13.0 (SPSS Inc., Chi-
cago, IL, USA).
The present study addresses the clinicopathological param-
eters of pregnancy and obstetric outcomes of patients with
endometrial cancer in these two groups.
Results
Between 1990 and 2005, 20 patients younger than 40 years of
age diagnosed with endometrial cancer were retrieved from the
Tumor Registry of Chang GungMemorial Hospital. Three cases
with Grade 1 adenocarcinoma had conception with seven
pregnancies that resulted in four successful deliveries, six live-
births, one ectopic pregnancy, and two fetal losses. One woman
underwent IVF for infertility. Complicated antepartum courses
such as gestational diabetes mellitus (GDM), preeclampsia, and
preterm delivery were noted in two of the three women. One
patient conceived twice and underwent hysterectomy during her
second cesarean surgery. Two patients received subsequent
hysterectomies after achieving successful livebirths. The details
of these patients are shown in Table 1.
Literature search identified 47 additional patients who had
documented endometrial cancer and conceived after conser-
vative treatment. All except one with an adenosquamous had
adenocarcinomas. Forty-four women had Grade 1 and three
had Grade 2 differentiation. Various progestin-based hormonal
regimens were used in most of these patients with a few added
tamoxifen.
Overall, Group 1 (n ¼ 14 women) had pregnancy after IVF,
intracytoplasmic sperm injection, gamete intrafallopian transfer,
or zygote intrafallopian transfer, and Group 2 (n ¼ 36 women)
consisted of cases who had spontaneous conception or had
ovulation induction with intrauterine insemination (Table 2).
Age at diagnosis (32.1 4.1 years vs. 29.5 5.3 years) and age
Table 2
Distribution of clinicopathological characteristics in the endometrial cancer patients with conception in the meta-analysis
Characteristics Patients no. Group 1 Group 2 p
Age at diagnosis, yr (mean  SD) 50 32.8  4.1 (n ¼ 14) 29.5  5.3 (n ¼ 36) 0.05
Age at pregnancy, yr (mean  SD) 43 34.3  4.0 (n ¼ 13) 30.9  5.3 (n ¼ 30) 0.05
Histology type 45 14 31 1.0
Adenocarcinoma 44 14 30
Adenosquamous 1 0 1
Grade of differentiation 41 14 27 1.0
Well 38 13 25
Moderate and poor 3 1 2
Hysterectomy after childbearing 50 14 36 0.70
Yes 9 3 6
No 41 11 30
Metastasis/recurrence 50 14 36 0.57
Yes 4 0 4
No 46 14 32
History of infertility 35 14 21 0.64
Yes 31 13 18
No 4 1 3
Ovulation induction rate 50 14 36 <0.001
Yes 24 14 10
No 26 0 26
Miscarriage rate 50 14 36 1.0
Yes 5 1 4
No 45 13 32
SD ¼ standard deviation.
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significantly different between the two groups ( p ¼ 0.05).
Group 1 had 23 livebirths including four sets of twins and two
sets of triplets, whereas 54 livebirths consisted of two sets of
twins and one set of triplets in Group 2. Table 3 shows 65
deliveries and their obstetric outcomes; Groups 1 and 2 had 15
and 50 deliveries, respectively. Group 1 had more multiple
gestations ( p ¼ 0.003), more preterm deliveries ( p ¼ 0.001),
higher cesarean rate ( p < 0.001), and more obstetrical compli-
cation ( p ¼ 0.035) than Group 2. One woman in Group 2
suffered from GDM with pregnancy induced hypertension,
whereas three women (1 case each had hemolysis, elevated liver
enzymes, and low platelet syndrome, preeclampsia, and GDM
with pregnancy induced hypertension) were found in Group 1.Table 3
Analyses of obstetric outcomes according to undergoing IVF, ICSI, gamete intraf
conception/intrauterine insemination (Group 2)
Group 1 (n¼15)
Preterm labor 7 (46.7)
Cesarean rate 14 (93.3)
Primigravida 14 (93.3)
Multiple pregnancy 6a (40.0)
Obstetric complications 3 (20.0) HELLP syndrome, preeclamp
a Four twins and two triplets; b Two twins and one triplet.
Data are presented as n(%).
GDM ¼ gestational diabetes mellitus; HELLP syndrome ¼ hemolysis, elevated
injection; IVF ¼ in vitro fertilization; PIH ¼ pregnancy induced hypertension.Discussion
Preserving reproductive potential has become an important
issue in endometrial cancer diagnosed in young women before
the age of 40 years because of delayed childbearing, and the
survival rates in these reproductive-age women with endome-
trial cancer are favorable. These women are frequently nulli-
gravid with history of infertility, but have strong desire to
preserve fertility. Pregnancies have been reported, mostly after
endometrial curettage and successful hormonal therapies for
early stage, low-grade endometrioid adenocarcinoma in young
women since 1968 [3e6,8e24]. The advent of efficient ART
helped in achieving successful pregnancies with increasing
reported cases after 1990 [25e34]. The rationale for immediateallopian transfer, or zygote intrafallopian transfer (Group 1) and spontaneous
Group 2 (n¼50) p
3 (6.0) 0.001
11 (22.0) <0.001
36 (72.0) 0.160
3b (6.0) 0.003
sia, GDM with PIH 1 (2.0) GDM with PIH 0.035
liver enzymes and low platelet syndrome; ICSI ¼ intracytoplasmic sperm
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unopposed estrogen stimulation with the risk of reinduction of
neoplastic endometrial lesion by estrogen [26]. Although these
cases were not numerous, clinical experience has shown the
effectiveness of such therapies in patients with early endome-
trial cancers.
It is evident that either megestrol acetate (megace) or
medroxyprogesterone acetate is effective for hormonal treatment
of early stage endometrial cancer after endometrial curettage
[12,17,35]. Common regimen includes megace (40e160 mg/
day) or medroxyprogesterone acetate (100e800 mg/day) for
6 months. The median length of treatment for complete response
was 3 months (range, 1e12 months) [35]. These patients were
followed up every 3e4 months by serial sonography, hystero-
scopy, transcervical resection of endometrial tissue for patho-
logical proof if necessary, and magnetic resonance imaging.
However, there was no consensus on the timing of ART, but to
initiate as soon as the patient achieved remission or after having
two consecutive normal endometrial samplings in periodic
samplings every 3e6 months [19].
This meta-analysis demonstrated a significant increase in
hypertensive disorders, preterm labor, multiple pregnancies, and
the incidence of cesarean delivery in infertile women undergone
ART. The increased cesarean rate in these women appears to
be associated with multiple pregnancies, preterm labor, and
obstetric complications. Increased number of multiple preg-
nancies in this study could be the result of ovulation induction
with gonadotropins and clomiphene citrate. The reason of
infertile women undergone ART might be because of chronic
anovulation. This also leads to increased number of GDM,
which may be reflected by glucose intolerance and other meta-
bolic disorders [36]. Nevertheless, placental abruption, placental
abnormalities, fetal chromosome, or structural abnormalities
were insignificant between women who underwent ART and
women who conceived spontaneously in this meta-analysis.
Long-term surveillance is required even after delivery for
the risk of cancer recurrence. Recurrences are common, with
a median of 40 months in the patients preserving fertility
[19,35]. Three cases had local recurrence including an early
ovarian metastasis after a successful term pregnancy in this
study [7,16,18]. Furthermore, a woman died of cancer
progression 8 months after a term delivery [21]. Hysterectomy
for the purpose of avoiding cancer recurrence after complete
childbearing is proposed [12].
Limitation of this study is inadequate data of collected
cases used for analysis because of some missing data.
However, the knowledge of ART and pregnancy complications
will be useful for physicians and the patients. Clinicians caring
for such patients should be vigilant for signs or symptoms of
GDM, preeclampsia, and preterm labor during antenatal care.
In conclusion, although young patients with endometrial
cancer should be validated on a large sample size, the
increasing number of successful conservative treatments with
adequate diagnostic facilities may allow tailored ART in
selected patients. The age may not play a key role in deciding
these young patients undergoing ART; chronic anovulation or
polycystic ovarian syndrome may interfere with these clinicalsettings. Nevertheless, ART patients were associated with
increased risk of preterm labor, preeclampsia, tended to have
multiple gestations and higher cesarean rate.References
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